Literature DB >> 23360899

Interaction between nitrous oxide, sevoflurane, and opioids: a response surface approach.

Hugo E M Vereecke1, Johannes H Proost, Bjorn Heyse, Douglas J Eleveld, Takasumi Katoh, Martin Luginbühl, Michel M R F Struys.   

Abstract

BACKGROUND: The interaction of sevoflurane and opioids can be described by response surface modeling using the hierarchical model. We expanded this for combined administration of sevoflurane, opioids, and 66 vol.% nitrous oxide (N2O), using historical data on the motor and hemodynamic responsiveness to incision, the minimal alveolar concentration, and minimal alveolar concentration to block autonomic reflexes to nociceptive stimuli, respectively.
METHODS: Four potential actions of 66 vol.% N2O were postulated: (1) N2O is equivalent to A ng/ml of fentanyl (additive); (2) N2O reduces C50 of fentanyl by factor B; (3) N2O is equivalent to X vol.% of sevoflurane (additive); (4) N2O reduces C50 of sevoflurane by factor Y. These four actions, and all combinations, were fitted on the data using NONMEM (version VI, Icon Development Solutions, Ellicott City, MD), assuming identical interaction parameters (A, B, X, Y) for movement and sympathetic responses.
RESULTS: Sixty-six volume percentage nitrous oxide evokes an additive effect corresponding to 0.27 ng/ml fentanyl (A) with an additive effect corresponding to 0.54 vol.% sevoflurane (X). Parameters B and Y did not improve the fit.
CONCLUSION: The effect of nitrous oxide can be incorporated into the hierarchical interaction model with a simple extension. The model can be used to predict the probability of movement and sympathetic responses during sevoflurane anesthesia taking into account interactions with opioids and 66 vol.% N2O.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360899     DOI: 10.1097/ALN.0b013e3182860486

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Automated gas control with the Maquet FLOW-i.

Authors:  Rik Carette; Andre M De Wolf; Jan F A Hendrickx
Journal:  J Clin Monit Comput       Date:  2015-06-14       Impact factor: 2.502

2.  Sevoflurane-induced isoelectric EEG and burst suppression: differential and antagonistic effect of added nitrous oxide.

Authors:  B Niu; J Y Xiao; Y Fang; B Y Zhou; J Li; F Cao; Y K Tian; W Mei
Journal:  Anaesthesia       Date:  2017-03-08       Impact factor: 6.955

3.  1-1-8 one-step sevoflurane wash-in scheme for low-flow anesthesia: simple, rapid, and predictable induction.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Naruemon Vattanasiriporn; Maneerat Thananun; Duangthida Nonlhaopol; Wilawan Somdee
Journal:  BMC Anesthesiol       Date:  2020-01-24       Impact factor: 2.217

4.  JM-1232(-) and propofol, a new combination of hypnotics with short-acting and non-cumulative preferable properties.

Authors:  Saori Taharabaru; Takahiro Tamura; Michiko Higashi; Naoyuki Matsuda; Maiko Satomoto; Yushi U Adachi; Aiji Boku Sato; Masahiro Okuda
Journal:  Exp Anim       Date:  2020-10-16

5.  Comparative study of analgesia nociception index (ANI) vs. standard pharmacokinetic pattern for guiding intraoperative fentanyl administration among mastectomy patients.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Pornlada Sukhong; Maneerat Thananun; Parinda Promkhote; Duangthida Nonlhaopol
Journal:  BMC Anesthesiol       Date:  2021-02-13       Impact factor: 2.217

6.  Efficacy of early goal-directed therapy using FloTrac/EV1000 to improve postoperative outcomes in patients undergoing off-pump coronary artery bypass surgery: a randomized controlled trial.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Kriangsak Ngamsaengsirisup; Sanpicha Sornpirom
Journal:  J Cardiothorac Surg       Date:  2022-08-21       Impact factor: 1.522

7.  Efficacy of Intraoperative Hemodynamic Optimization Using FloTrac/EV1000 Platform for Early Goal-Directed Therapy to Improve Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Graft with Cardiopulmonary Bypass: A Randomized Controlled Trial.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Kriangsak Ngamsangsirisup; Krisana Nongnuang
Journal:  Med Devices (Auckl)       Date:  2021-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.